Viewing Study NCT04997850

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-05-07 @ 7:34 AM
Study NCT ID: NCT04997850
Status: COMPLETED
Last Update Posted: 2025-08-29
First Post: 2021-03-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma
Sponsor: Xinrui Zhu，MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma Non-resectable View
None Transarterial Chemoembolization View
None Tyrosine Kinase Inhibitor View
None Immune Checkpoint Blockade View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular Carcinoma Non-resectable View
None transarterial chemoembolization View
None tyrosine kinase inhibitor View
None immune checkpoint blockade View